Company Response to Trading Volume Query
Date of Communication: September 02, 2026
Nature of Exchange Query
Caplin Point Laboratories Limited received an email from the National Stock Exchange of India Limited (NSE) on September 01, 2026 regarding a significant increase in trading volume of the company's equity shares across exchanges in the recent past.
Company's Clarification on Trading Volume
The company states that it has duly made all requisite disclosures in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirms it has not withheld any material or price-sensitive information that would have bearing on the volume/price behavior of its shares.
The increase in trading volume is described as "purely market driven" and the company states it is "not aware of any specific reasons contributing to the same."
Regulatory Compliance Reference
The company specifically references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including all material events and price sensitive information having a bearing on the company's operations/performance. The company reaffirms its continued commitment to comply with all applicable disclosure requirements under these regulations as amended from time to time.